Rotavirus enterotoxin NSP4 has mucosal adjuvant properties

Vaccine

Volumn 28, Issue 18, 2010, Pages 3106-3111

  Kavanagh, Owen V ^a   Ajami, Nadim J ^a,b   Cheng, Elly ^a   Ciarlet, Max ^a   Guerrero, Roberto A ^a   Zeng, Carl Q Y ^a   Crawford, Sue E ^a   Estes, Mary K ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

Adjuvant; Intranasal; NSP4; Rotavirus

Indexed keywords

IMMUNOLOGICAL ADJUVANT; KEYHOLE LIMPET HEMOCYANIN; NONSTRUCTURAL PROTEIN 4; OVALBUMIN; ROTAVIRUS VACCINE; TETANUS TOXOID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; FEMALE; IMMUNOGENICITY; MOUSE; MUCOSAL IMMUNITY; NONHUMAN; PRIORITY JOURNAL; ROTAVIRUS INFECTION; VACCINATION; VIRUS RESISTANCE;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, INTRANASAL; ANIMALS; ANTIBODIES; FEMALE; GLYCOPROTEINS; HEMOCYANIN; IMMUNITY, MUCOSAL; MICE; OVALBUMIN; TETANUS TOXOID; TOXINS, BIOLOGICAL; VACCINES; VIRAL NONSTRUCTURAL PROTEINS;

EID: 77949659048     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2010.02.063     Document Type: Article

References (28)

1. Hasegawa H., Ichinohe T., Ainai A., Tamura S., and Kurata T. Development of mucosal adjuvants for intranasal vaccine for H5N1 influenza viruses. Ther Clin Risk Manag 5 1 (2009) 125-132
2. Stanley M., Gissmann L., and Nardelli-Haefliger D. Immunobiology of human papillomavirus infection and vaccination-implications for second generation vaccines. Vaccine 26 Suppl. 10 (2008) K62-K67
3. Lehner T., Bergmeier L., Wang Y., Tao L., and Mitchell E. A rational basis for mucosal vaccination against HIV infection. Immunol Rev 170 (1999) 183-196
4. Schnitzler A.C., Burke J.M., and Wetzler L.M. Induction of cell signaling events by the cholera toxin B subunit in antigen-presenting cells. Infect Immun 75 6 (2007) 3150-3159
5. van Ginkel F.W., Jackson R.J., Yuki Y., and McGhee J.R. Cutting edge: the mucosal adjuvant cholera toxin redirects vaccine proteins into olfactory tissues. J Immunol 165 9 (2000) 4778-4782
6. Couch R.B. Nasal vaccination, Escherichia coli enterotoxin, and Bell's palsy. N Engl J Med 350 9 (2004) 860-861
7. Hagiwara Y., Kawamura Y.I., Kataoka K., Rahima B., Jackson R.J., Komase K., et al. A second generation of double mutant cholera toxin adjuvants: enhanced immunity without intracellular trafficking. J Immunol 177 5 (2006) 3045-3054
8. Ball J.M., Tian P., Zeng C.Q., Morris A.P., and Estes M.K. Age-dependent diarrhea induced by a rotaviral nonstructural glycoprotein. Science 272 5258 (1996) 101-104
9. Zhang M., Zeng C.Q., Morris A.P., and Estes M.K. A functional NSP4 enterotoxin peptide secreted from rotavirus-infected cells. J Virol 74 24 (2000) 11663-11670
10. Guerrero R.A., Ball J.M., Krater S.S., Pacheco S.E., Clements J.D., and Estes M.K. Recombinant Norwalk virus-like particles administered intranasally to mice induce systemic and mucosal (fecal and vaginal) immune responses. J Virol 75 20 (2001) 9713-9722
11. O'Neal C.M., Crawford S.E., Estes M.K., and Conner M.E. Rotavirus virus-like particles administered mucosally induce protective immunity. J Virol 71 11 (1997) 8707-8717
12. Zhang M., Zeng C.Q., Dong Y., Ball J.M., Saif L.J., Morris A.P., et al. Mutations in rotavirus nonstructural glycoprotein NSP4 are associated with altered virus virulence. J Virol 72 5 (1998) 3666-3672
13. Dong Y., Zeng C.Q., Ball J.M., Estes M.K., and Morris A.P. The rotavirus enterotoxin NSP4 mobilizes intracellular calcium in human intestinal cells by stimulating phospholipase C-mediated inositol 1,4,5-trisphosphate production. Proc Natl Acad Sci USA 94 8 (1997) 3960-3965
14. Zeng C.Q., Estes M.K., Charpilienne A., and Cohen J. The N terminus of rotavirus VP2 is necessary for encapsidation of VP1 and VP3. J Virol 72 1 (1998) 201-208
15. Bertolotti-Ciarlet A., Ciarlet M., Crawford S.E., Conner M.E., and Estes M.K. Immunogenicity and protective efficacy of rotavirus 2/6-virus-like particles produced by a dual baculovirus expression vector and administered intramuscularly, intranasally, or orally to mice. Vaccine 21 25-26 (2003) 3885-3900
16. Dickinson B.L., and Clements J.D. Dissociation of Escherichia coli heat-labile enterotoxin adjuvanticity from ADP-ribosyltransferase activity. Infect Immun 63 5 (1995) 1617-1623
17. Ball J.M., Hardy M.E., Atmar R.L., Conner M.E., and Estes M.K. Oral immunization with recombinant Norwalk virus-like particles induces a systemic and mucosal immune response in mice. J Virol 72 2 (1998) 1345-1353
18. Franco M.A., and Greenberg H.B. Role of B cells and cytotoxic T lymphocytes in clearance of and immunity to rotavirus infection in mice. J Virol 69 12 (1995) 7800-7806
19. Bohl E.H., Theil K.W., and Saif L.J. Isolation and serotyping of porcine rotaviruses and antigenic comparison with other rotaviruses. J Clin Microbiol 19 2 (1984) 105-111
20. Cheng E., Cardenas-Freytag L., and Clements J.D. The role of cAMP in mucosal adjuvanticity of Escherichia coli heat-labile enterotoxin (LT). Vaccine 18 1-2 (1999) 38-49
21. Marinaro M., Fasano A., and De Magistris M.T. Zonula occludens toxin acts as an adjuvant through different mucosal routes and induces protective immune responses. Infect Immun 71 4 (2003) 1897-1902
22. Marinaro M., Di Tommaso A., Uzzau S., Fasano A., and De Magistris M.T. Zonula occludens toxin is a powerful mucosal adjuvant for intranasally delivered antigens. Infect Immun 67 3 (1999) 1287-1291
23. Tafazoli F., Zeng C.Q., Estes M.K., Magnusson K.E., and Svensson L. NSP4 enterotoxin of rotavirus induces paracellular leakage in polarized epithelial cells. J Virol 75 3 (2001) 1540-1546
24. Seo N.S., Zeng C.Q., Hyser J.M., Utama B., Crawford S.E., Kim K.J., et al. Inaugural article: integrins alpha1beta1 and alpha2beta1 are receptors for the rotavirus enterotoxin. Proc Natl Acad Sci USA 105 26 (2008) 8811-8818
25. Dietl J., Ruck P., Marzusch K., Horny H.P., Kaiserling E., and Handgretinger R. Uterine granular lymphocytes are activated natural killer cells expressing VLA-1. Immunol Today 13 6 (1992) p236
26. Perez-Villar J.J., Melero I., Gismondi A., Santoni A., and Lopez-Botet M. Functional analysis of alpha 1 beta 1 integrin in human natural killer cells. Eur J Immunol 26 9 (1996) 2023-2029
27. Rubio M.A., Sotillos M., Jochems G., Alvarez V., and Corbi A.L. Monocyte activation: rapid induction of alpha 1/beta 1 (VLA-1) integrin expression by lipopolysaccharide and interferon-gamma. Eur J Immunol 25 9 (1995) 2701-2705
28. Buonaguro F.M., Tornesello M.L., and Buonaguro L. Virus-like particle vaccines and adjuvants: the HPV paradigm. Expert Rev Vaccines 8 10 (2009) 1379-1398